Pluristem Achieves Milestone Towards Completion of its New GMP Manufacturing Facility for Commercial Production of PLX Cells

[at noodls] – Pluristem Achieves Milestone Towards Completion of its New GMP Manufacturing Facility for Commercial Production of PLX Cells , October 23, 2012 – Pluristem Therapeutics, Inc.(NASDAQCM:PSTI; TASE:PLTR), … more

View todays social media effects on PSTI

View the latest stocks trending across Twitter. Click to view dashboard